Latest AI and machine learning research in colon cancer for healthcare professionals.
Colorectal cancer is the third leading cause of cancer-related deaths in the United States, and colonoscopy remains the gold standard for early detection and prevention. However, many procedures are postponed due to inadequate bowel preparation, a preventable failure often caused by patients’ difficulty in understanding or following written prep instructions. Prior interventions such as reminder a...
Homologous recombination deficiency (HRD) confers sensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors and platinum-based chemotherapy, representing a critical biomarker for precision oncology across multiple malignancies. Current HRD assessment relies on next-generation sequencing of genomic scar signatures, but specialized infrastructure requirements, high costs, and prolonged turnaroun...
Early cancer detection substantially improves patient survival, yet conventional screening methods are directed at single anatomical sites and inadequ...
Cancer remains one of the most significant global health challenges. De-spite advances in treatment, early detection remains a critical concern. The i...
Early-onset colorectal cancer (EOCRC) continues to rise, with the steepest increases observed among Hispanic/Latino (H/L) populations, underscoring th...
The incidence of early-onset colorectal cancer (EOCRC; <50 years) is rising rapidly among populations. Although alterations in the RTK-RAS signaling p...
Identification of minimally invasive biomarkers of different stages of cachexia (Ca), and precachexia (PCa) in particular, might help clinicians in tr...
Colorectal cancer (CRC) exhibits marked heterogeneity across age, ancestry, and treatment context, underscored by the rising incidence of early-onset ...
OBJECTIVE: To develop a non-invasive, radiation-free model for early colorectal adenoma prediction using clinical electronic medical record (EMR) data...
BACKGROUND: Colorectal cancer (CRC) is one of the leading contributors to cancer-related deaths worldwide, with more than 900,000 new diagnoses and re...
BACKGROUND: Mounting evidence indicates that lung adenocarcinoma (LUAD) patients are at elevated risk for venous thromboembolism (VTE), presenting a m...
BACKGROUND AND STUDY AIMS: Polyp size is crucial for determining colonoscopy surveillance intervals. We present an artificial intelligence (AI) model ...
BACKGROUND: Colorectal cancer is the third most common malignant tumor with the third highest incidence rate. Distant metastasis is the main cause of ...
BACKGROUND: Lung adenocarcinoma (LUAD) is a major cause of cancer-related mortality worldwide. Tumor-associated macrophages (TAMs) play a crucial role...
BACKGROUND: Determining the KRAS gene mutation status in colorectal cancer (CRC) before surgery is highly important for an individualized clinical tre...
BACKGROUND: Lung adenocarcinoma (LUAD) is a major cause of cancer mortality. Considering the critical role of tumor infiltrating lymphocytes in effect...
The important function of microbiota as therapeutic modulators and diagnostic biomarkers in cancer has been shown by recent developments in microbiome...
Elevated consumption of sugar-sweetened beverages (SSBs) has been associated with an increase in obesity, type 2 diabetes, and other non-communicable ...
INTRODUCTION: The differential expression of miRNAs, a key regulator in many cell signaling pathways, has been studied in various malignancies and may...
BACKGROUND/AIM: This study evaluated the diagnostic accuracy (DA) for colorectal adenomas (CRA), screened by fecal immunochemical test (FIT), using fi...